Research
The report also explores how microdosing may impact the use of other prescribed mental health medications....
Nine out of the 11 chronic pain sufferers interviewed say they experienced some kind of lasting pain reduction while self-medicating...
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS....
This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol...
After two long years of preparing documents and presenting to various committees, the program is in its final stages, and...
“We know nothing scientific about psychedelics and people of color and how appropriate our treatments are for people in those...
“After adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent...
"Our goal is to provide insight on key parameters that may impact and explain the mechanisms behind low-dose treatments," says...
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David...
